| abstract |
The present invention relates to heteroaryl compounds as MEK inhibitors. The present invention includes a heteroaryl compound of formula (I), a tautomer thereof and a pharmaceutically acceptable salt, a combination with a suitable drug, and a pharmaceutical composition thereof. The present invention also encompasses methods of making the compounds and methods of their intended use in therapy. (I) (I) |